Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

9.575 +0.325 (+3.51%)

Streaming Delayed Price Updated: 11:07 AM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Biotech Sector Working Fast to Combat Alzheimer’s Disease Cases That are Set to Explode

March 15, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 15, 2023 – USA News Group – According to a 2022 study of more than 6 million patients 65 and older, the risk factor for...

Via FinancialNewsMedia

Prothena to Highlight Next Generation Treatments for Alzheimer’s and Parkinson’s Disease at the AD/PD 2023 Meeting

March 14, 2023

From Prothena Corporation plc

Via Business Wire

Prothena Reports Fourth Quarter and Full Year 2022 Financial Results, and Provides Financial Guidance and Business Highlights

February 23, 2023

From Prothena Corporation plc

Via Business Wire

Earnings Outlook For Prothena Corp ↗

February 22, 2023

Via Benzinga

Prothena Touts Encouraging Data From Early-Stage Alzheimer's Candidate ↗

February 01, 2023

Via Benzinga

Analyst Expectations for Prothena Corp's Future ↗

December 21, 2022

Via Benzinga

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

Prothena to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

February 16, 2023

From Prothena Corporation plc

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 14, 2023

Via Benzinga

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 03, 2023

From Prothena Corporation plc

Via Business Wire

Cantor Fitzgerald Maintains Overweight Rating for Prothena Corp: Here's What You Need To Know ↗

December 21, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About Prothena Corp ↗

November 04, 2022

Within the last quarter, Prothena Corp (NASDAQ:PRTA) has observed the following analyst ratings:

Via Benzinga

Recap: Prothena Corp Q3 Earnings ↗

November 03, 2022

Prothena Corp (NASDAQ:PRTA) reported its Q3 earnings results on Thursday, November 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Prothena Reports Topline Phase 1 Single Ascending Dose Study Results of PRX005, a Novel Anti-MTBR-Tau Antibody for the Potential Treatment of Alzheimer’s Disease

January 31, 2023

From Prothena Corporation plc

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023 ↗

January 27, 2023

Via Benzinga

Biotech Bonanza: 2023 Biotech Outlook As The Fed Remains Hawkish ↗

January 11, 2023

2023 can be the year of biotechs after two consecutive years of negative or barely positive returns.

Via Talk Markets

How To Weather These Choppy Markets ↗

December 22, 2022

Until we get an absolute bottom in the markets, the best way to avoid experiencing a devastating permanent loss of capital is to keep away from stocks with deteriorating fundamentals and heavy insider...

Via Talk Markets

Top Biotech Companies Are Making Steady Progress In Developing Treatments To Fight Alzheimer’s Disease ↗

December 21, 2022

The estimated cost of Alzheimer's disease and related dementia (ADRD) care in 2021 was $355 billion. Investing in the top companies that are making steady progress toward developing a treatment for...

Via Talk Markets

Prothena Announces Pricing of Public Offering of 3,250,000 Ordinary Shares

December 14, 2022

From Prothena Corporation plc

Via Business Wire

Why Prothena Shares Are Trading Lower ↗

December 14, 2022

Prothena Corporation PLC (NASDAQ: PRTA) shares are trading lower by 6.53% to $59.10 during Wednesday morning. The company announced that it has commenced an underwritten public offering of 3,000,000 of...

Via Benzinga

Why Prothena Shares Are Nosediving During Tuesday's After-Hours Session ↗

December 13, 2022

Prothena Corporation PLC (NASDAQ: PRTA) shares are trading lower by some 8.35% to $57.95 during Tuesday's after-hours session. The company announced that it has commenced an underwritten public...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 13, 2022

Via Benzinga

Prothena Announces Proposed Public Offering of Ordinary Shares

December 13, 2022

From Prothena Corporation plc

Via Business Wire

Prothena Presents Data Demonstrating Consistent Survival Benefit Observed with Birtamimab in Mayo Stage IV AL Amyloidosis Patients in Phase 3 VITAL Study at ASH 2022

December 12, 2022

From Prothena Corporation plc

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

November 22, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Prothena Announces Achievement of $40 Million Clinical Milestone Payment from Novo Nordisk for PRX004/NNC6019 Under Investigation for the Treatment of ATTR Cardiomyopathy

November 21, 2022

From Prothena Corporation plc

Via Business Wire

Roche's Alzheimer's Drug Fails In Phase 3; Here's The Fallout For Biogen, Lilly, Prothena And Others ↗

November 14, 2022

Biogen rose on Roche's Alzheimer's failure as a potential competitor drops off the map.

Via Investor's Business Daily

Prothena Reports Third Quarter 2022 Financial Results and Business Highlights

November 03, 2022

From Prothena Corporation plc

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022 ↗

November 04, 2022

Upgrades

Via Benzinga

Prothena to Present Data on Survival Benefit Observed in Completed Phase 3 Study of Drug Candidate Birtamimab in Patients with Mayo Stage IV AL Amyloidosis at the ASH 2022 Meeting

November 03, 2022

From Prothena Corporation plc

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.